
Astrazeneca Pharma India Ltd is Rated Hold
2026-11-20 10:11:27Astrazeneca Pharma India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-11-16 08:02:41Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined sharply, reflecting a downgrade in its technical grade from Sell to Hold, amid a broader context of subdued market performance and sector-specific pressures.
Read More
Astrazeneca Pharma India Ltd is Rated Hold
2026-11-09 10:10:40Astrazeneca Pharma India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Astrazeneca Pharma India Ltd is Rated Sell
2026-10-29 10:10:02Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 2 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 October 2026, providing investors with an up-to-date view of its performance and outlook.
Read More
Astrazeneca Pharma India Ltd is Rated Sell
2026-10-18 10:10:04Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 5792.55 as Sell-Off Deepens
2026-10-08 12:38:14Astrazeneca Pharma India Ltd has slipped to a fresh 52-week low of Rs 5792.55 on 8 Oct 2026, extending its recent downward trajectory amid broader market weakness and company-specific headwinds. The stock has now declined by 2.73% over the past two sessions, underperforming its sector and the benchmark indices.
Read More
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 5,870 Amidst Prolonged Downtrend
2026-10-07 10:36:49A sustained decline has pushed Astrazeneca Pharma India Ltd to a fresh 52-week low of Rs 5,870.05 on 7 Oct 2026, marking a significant 37.26% drop over the past year, far outpacing the broader Sensex's 11.10% decline over the same period.
Read More
Astrazeneca Pharma India Ltd is Rated Sell
2026-10-07 10:10:03Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read More
Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 5,888 Amid Prolonged Downtrend
2026-10-06 11:35:30For the ninth consecutive session, Astrazeneca Pharma India Ltd has closed lower, slipping to a fresh 52-week low of Rs 5,888.25 on 6 Oct 2026, marking a cumulative decline of 12.27% over this period and extending its year-long underperformance relative to the broader market.
Read MoreLetter Of Intent With Strand Life Sciences Private Limited - Disclosure Of Linkedin Communication
17-Nov-2026 | Source : BSEPlease find the enclosed intimation of the Company as per the captioned subject for your reference.
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
17-Nov-2026 | Source : BSEPlease find the enclosed document of the Company as per the captioned subject for your reference.
Revised Submission With Functional Link - Letter Of Intent With Strand Life Sciences Private Limited - Disclosure Of Linkedin Communication
17-Nov-2026 | Source : BSEPlease find the enclosed document of the Company as per the captioned subject. This is being resubmitted as the weblink was not correctly re-directing to the relevant web page in the earlier submission. Kindly take this submission on record.
Corporate Actions
No Upcoming Board Meetings
Astrazeneca Pharma India Ltd has declared 1800% dividend, ex-date: 31 Jul 26
Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06
No Bonus history available
No Rights history available